Live kidney donation offers several advantages over cadaveric organ transplantation but requires shared decision-making among the clinician and potential donor, where perceived benefits of kidney donation must be balanced against the potential risks of donor nephrectomy and related comorbidities. Women make up the majority of living kidney donors. In 2015, 63% of living donors were female in which 64% were of childbearing age 1,2 and may wish to become pregnant in the future. Importantly, there are several adaptive changes in renal physiology during normal gestation, including an increase in renal plasma flow and glomerular filtration rate that culminates in an increase in kidney volume up to 70%. 3, 4 In contrast, there is a significant reduction in overall glomerular filtration of 30% at 1 year following donor nephrectomy despite compensatory hypertrophy and hyperfiltration in the remaining kidney. 5, 6 These observations have engendered concerns about the risk of donor nephrectomy on maternal and fetal outcomes. 
| INTRODUC TI ON
Live kidney donation offers several advantages over cadaveric organ transplantation but requires shared decision-making among the clinician and potential donor, where perceived benefits of kidney donation must be balanced against the potential risks of donor nephrectomy and related comorbidities. Women make up the majority of living kidney donors. In 2015, 63% of living donors were female in which 64% were of childbearing age 1, 2 and may wish to become pregnant in the future. Importantly, there are several adaptive changes in renal physiology during normal gestation, including an increase in renal plasma flow and glomerular filtration rate that culminates in an increase in kidney volume up to 70%. 3, 4 In contrast, there is a significant reduction in overall glomerular filtration of 30% at 1 year following donor nephrectomy despite compensatory hypertrophy and hyperfiltration in the remaining kidney. 5, 6 These observations have engendered concerns about the risk of donor nephrectomy on maternal and fetal outcomes.
There is limited and conflicting data in female kidney donors of childbearing age to guide the informed consent process. Prior studies were small, retrospective, single-center experiences, 7, 8 compared outcomes to randomly sampled controls, 10 or were based on surveys, 11 making it difficult to interpret results. 12, 13 To date, there has been only one study comparing maternal and fetal outcomes to matched controls, which demonstrated an increased risk in the combined outcome of gestational hypertension and preeclampsia. 15 The purpose of this study was to broaden our understanding of pregnancy-associated risks following kidney donation by examining adverse maternal and fetal outcomes in first pregnancies of live donors compared with similarly healthy nondonor counterparts.
| MATERIAL S AND ME THODS
A matched cohort study was performed using the Intermountain This project was reviewed by the Intermountain Healthcare IRB, Protocol #1040486 and has been determined to be exempt from the federal rules governing "human subjects research" and informed consent was not required. 17 
| Cohort definition
The study sample included all adult female patients admitted for childbirth from 1996 through 2015. All participants were required to have clinical and administrative data in the Intermountain Healthcare System. We only included primiparous women and singleton births to reduce bias toward delivery modes ( Figure 1 ). Women with kidney donation prior to their first pregnancy were identified through ICD-9 code V59.4. 18 Women with a solitary kidney due to renal agenesis (N = 228), those with a history of chronic kidney disease (CKD; N = 32), those with a history of chronic hypertension (N = 102), and those with a history of diabetes (N = 51) were excluded from the analysis. A woman was considered to have CKD if a Charlson ICD-9 
| Matching
Using a pool of 4710 primiparous women with two kidneys, 59
women who had donated a kidney were matched 1:4 to women with two kidneys by age at delivery (within 2 years) and race. Approach of nearest available neighbor matching without replacement was used. 19 
| Outcomes
Outcomes were chosen based on previous studies examining adverse outcomes in pregnancy. 12, 17, 20 Adverse outcomes were de- 
| Statistical analysis
Descriptive statistics were used to summarize characteristics of women with and without a prior history of kidney donation.
Percentages were used for categorical data and mean ± SD was used for continuous data. Conditional logistic regression models were used to compare outcomes between the matched set data. We considered a finding to be statistically significant for 2-sided P < 0.05.
Since age is a risk factor for preeclampsia, we performed a subgroup analysis stratifying by age ≤30 years vs >30 years and examined all outcomes using conditional logistic regression models. All statistical analyses were performed with SAS software, version 9.14 (SAS Institute, Cary, NC, USA).
| RE SULTS
Using a random pool of 4710 women with two kidneys (Figure 1 ), 59
women with a history of donor nephrectomy were matched 1:4 by age and race with women with two kidneys (N = 236). Mean (SD) age at delivery (years) among donors and nondonors was 30.4 ± 5.5 and 29.6 ± 5.5, respectively. Over 90% of the women were white. The mean (SD) time from kidney donation to delivery was 2.7 ± 1.8 years.
The prevalence of adverse maternal and neonatal outcomes in donors and nondonors is shown in 
| D ISCUSS I ON
In our cohort, we found the risk of preterm delivery, delivery via cesarean section, gestational hypertension, gestational diabetes, length of stay in the hospital and low birthweight was similar between donors and nondonors. We did find a trend toward an increased risk of preeclampsia/eclampsia in the entire cohort but it did not reach statistical significance. However, a novel finding of our study is that primiparous kidney donors ≤30 years of age had a fourfold increased risk of preeclampsia/eclampsia than nondonors.
Our findings suggest that while the majority of women had uncomplicated pregnancies after donation, younger female donors without previous pregnancies may be at a higher risk of preeclampsia/ eclampsia.
This study expands upon prior data examining pregnancy outcomes after kidney donation. A study using data from the Norwegian Birth Registry, examined pregnancy outcomes in 326 kidney donors using a control group of randomly sampled births. Similar to our findings, they found no increased risk of preterm birth, low birthweight, gestational hypertension or preeclampsia in the main analysis. 10 However, when they examined outcomes in women who were pregnant before donation with outcomes in pregnancy postdonation, they found an increased risk of preeclampsia postdonation.
However, the number of women included in this secondary analysis was small and on average, kidney donors in this study were 5 years older than the nondonors and the analysis did not adjust for this difference. Another study of 1085 pregnancies found a similar rate of pregnancy complications between kidney donors and the general population. 11 However, women who had predonation pregnancies and postdonation pregnancies were more likely to have adverse maternal outcomes postdonation. 11 Specifically, they found a sevenfold increased risk of preeclampsia in adjusted analysis. Limitations of this study include that all data was self-reported on patient surveys completed on average 12 years after first pregnancies and 4 years after postdonation pregnancies and the loss to follow-up after donation was >24%. 11 We limited our analysis to only primiparous women to avoid bias with delivery modes and to exclude women with previous history of preeclampsia so were unable to examine adverse pregnancy outcomes in pre-vs postdonation.
Similar to our study design was a recent study of 85 living donors matched to 510 controls by age, race, income, urban or rural residence, and previous pregnancy numbers in Canada. 15 This study found an increased risk of the combined outcome of preeclampsia and gestational hypertension (OR: 2.4, 95% CI: 1.2-5.0) in kidney donors. 15 There was no difference in secondary outcomes, including gestational hypertension and preeclampsia alone. 15 We found a trend toward an increased risk of preeclampsia in our study with a similar OR to the previous study (OR: 2.96, 95% CI: 0.98-8.94) but it did not reach statistical significance (P = 0.06). We found that kidney donation was not associated with gestational hypertension or with the combined endpoint of preeclampsia and gestational hypertension. Given our small number of patients, it is possible that we were underpowered to detect this difference. However, we did find a fourfold increased risk of preeclampsia/eclampsia in kidney donors ≤30 years of age. Interestingly, in a subgroup analysis of the Canadian study, female donors ≤32 years of age did not have an increased risk of preeclampsia/gestational hypertension but female donors >32 years of age did. On average, the subjects in the Canadian cohort were 2 years older than the subjects in our cohort.
Extremes of age are associated with preeclampsia, but usually the risk is greater in older women (age >40 years). 21 In the younger population, once adjustments for parity are made the association between younger age and preeclampsia is usually lost. 22 It is well known that parity influences preeclampsia risk with the highest risk in first pregnancies and most first pregnancies usually occur at a younger age. 23 We only included first pregnancies, whereas only 46% of the pregnancies in the previous study were first pregnancies.
However, in a subgroup analysis of the Canadian study, primiparous female donors had a significantly higher risk of preeclampsia/gestational hypertension compared to nondonors but multiparous female donors did not. Hence, nulliparous potential kidney donors may be at higher risk of preeclampsia than multiparous donors and should be counseled on this risk.
We only included singleton births as multiple gestation is associated with an increased risk of adverse pregnancy outcomes including preeclampsia, 24 whereas previous studies included all pregnancies.
Ninety-three percent of our study population was white and the majority of the Canadian population (70%) was white. Obesity is a significant factor that can influence pregnancy outcomes including Factors that are responsible for the increased risk of gestational hypertension and preeclampsia in kidney donors are unknown.
Kidney donation does result in a reduction in overall kidney function.
Even women with mild kidney damage and normal glomerular filtration rate have an increased risk of adverse pregnancy outcomes. 27, 28 The cause of increased pregnancy complications in these women is unknown but may be due to endothelial damage, inflammation and oxidative stress, all of which occur with even mild kidney damage. 29, 30 Mildly reduced kidney function during pregnancy resulting from kidney donation may be enough to predispose to gestational hypertension and preeclampsia. Additionally, hypertensive disorders of pregnancy in the general population are associated with earlier and higher rates of developing chronic kidney disease. 31 Hence, female donors who develop gestational hypertension and preeclampsia should be monitored long-term to determine if there are higher rates of developing chronic kidney disease. Further studies in pregnant kidney donors are needed to determine the potential mechanisms by which donation may lead to adverse pregnancy outcomes.
Our study has several strengths. It includes a large contemporary cohort of women from a registry of one of the largest health care providers in the Intermountain West. We have complete laboratory and administrative data, and this database has been used for other published studies. 17, 20, 32 Additionally, to our knowledge, we are the first to study only primiparous women. Primiparous women have a higher risk of preeclampsia and thus may be at higher risk for adverse complications. 23 Only studying primiparous women also reduced bias as women who have had a previous preterm birth are at a higher risk of a recurrent preterm birth and women who have had a prior cesarean section may only be a candidate for a repeat cesarean section.
There are several limitations to this study. Our analysis mainly included women of white race and does not represent other races/ ethnicities that collectively comprise approximately 30% of live donors and who may have a higher baseline risk of pregnancy-related complications. 33, 34 Secondly, we identified women with a history of donation of a kidney by ICD-9 code rather than chart reviews.
Additionally, we identified comorbidities by ICD-9 code and data regarding smoking and laboratory values for renal function were not available in our cohort. All outcomes were also identified by ICD-9 code, and errors or misclassification in coding is possible.
Additionally, we were unable to determine the severity of preeclampsia/eclampsia from the dataset. BMI data was only available in a small group of women. We did not have data regarding income or rural or urban residency to match on those factors. We were not able to examine whether the extremes of age (>40 or <20 years) were risk factors for preeclampsia given the small number of female donors that fell into these categories. Additionally, we did not have data on prenatal care including ultrasound scans and routine follow-up visits. We also did not have information on PAPP-A protein levels.
Low titers of PAPP-A protein levels may indicate higher risk of preeclampsia. 35 Finally, since this is an observational study it may be subject to residual confounding. 36 Our study suggests that the risk of pregnancy-associated complications following kidney donation is small. While there appears to be an increased risk of preeclampsia, there is no increased risk of preterm delivery, delivery via cesarean section or low birthweight.
As such, the majority of female donors can expect a normal pregnancy. Potential donor candidates should be counseled regarding the possible complications of pregnancy including the risk of preeclampsia and gestational hypertension, especially in younger nulliparous women.
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